Gene silencing at the gene expression level of ABC transporters using anti-sense oligonucleotides or double-stranded small interference RNAs (siRNA) to regulate mRNA levels or target the signaling pathways that induce ABC transporters expression has been reported to counter multi-drug resistance in mammalian cancer research [110,111]. The gene discussed is ABCG2; the disease is cancer.